Literature DB >> 15081264

OTK18 expression in brain mononuclear phagocytes parallels the severity of HIV-1 encephalitis.

Kimberly A Carlson1, Jenae Limoges, Garrett D Pohlman, Larisa Y Poluektova, Dianne Langford, Eliezer Masliah, Tsuneya Ikezu, Howard E Gendelman.   

Abstract

OTK18 was isolated by mRNA differential display of human monocyte-derived macrophages (MDM) infected with human immunodeficiency virus type one (HIV-1). Northern blot and real-time reverse transcription polymerase chain reaction showed low levels of OTK18 expression in human tissue, which markedly increased during advanced HIV-1 encephalitis (HIVE). Immunocytochemistry, using rabbit polyclonal antisera, showed OTK18 localized to brain mononuclear phagocytes (MP) in moderate to severe HIV-1 encephalitis. OTK18 expression was selective and not found in HIV-1-infected brain tissue with limited neuropathological abnormalities, nor in cytomegalovirus encephalitis, multiple sclerosis, Alzheimer's disease, or uninfected control brains. Thus, OTK18 expression in brain mononuclear phagocytes is a signature for advanced HIV-1 encephalitis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15081264     DOI: 10.1016/j.jneuroim.2004.01.021

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  14 in total

1.  The transcriptional repressor K-RBP modulates RTA-mediated transactivation and lytic replication of Kaposi's sarcoma-associated herpesvirus.

Authors:  Zhilong Yang; Charles Wood
Journal:  J Virol       Date:  2007-04-04       Impact factor: 5.103

2.  OTK18, a zinc-finger protein, regulates human immunodeficiency virus type 1 long terminal repeat through two distinct regulatory regions.

Authors:  Masahide Horiba; Lindsey B Martinez; James L Buescher; Shinji Sato; Jenae Limoges; Yunquan Jiang; Clinton Jones; Tsuneya Ikezu
Journal:  J Gen Virol       Date:  2007-01       Impact factor: 3.891

3.  Pathogenesis of Human Immunodeficiency Virus Type-1 (HIV-1)-Associated Dementia: Role of Voltage-Gated Potassium Channels.

Authors:  James P Keblesh; Benjamin C Reiner; Jianuo Liu; Huangui Xiong
Journal:  Retrovirology (Auckl)       Date:  2008

Review 4.  Voltage-gated potassium channels in human immunodeficiency virus type-1 (HIV-1)-associated neurocognitive disorders.

Authors:  James Keblesh; Dehui Hu; Huangui Xiong
Journal:  J Neuroimmune Pharmacol       Date:  2008-05-06       Impact factor: 4.147

Review 5.  NeuroAIDS: characteristics and diagnosis of the neurological complications of AIDS.

Authors:  Alireza Minagar; Deborah Commins; J Steven Alexander; Romy Hoque; Francesco Chiappelli; Elyse J Singer; Behrooz Nikbin; Paul Shapshak
Journal:  Mol Diagn Ther       Date:  2008       Impact factor: 4.074

Review 6.  Molecular mechanisms of HIV-1 persistence in the monocyte-macrophage lineage.

Authors:  Valentin Le Douce; Georges Herbein; Olivier Rohr; Christian Schwartz
Journal:  Retrovirology       Date:  2010-04-09       Impact factor: 4.602

7.  Calpain and proteasomal regulation of antiretroviral zinc finger protein OTK18 in human macrophages: visualization in live cells by intramolecular FRET.

Authors:  Lindsey B Martinez; Shannon M Walsh; Michael T Jacobsen; Shinji Sato; Jayme Wiederin; Pawel Ciborowski; Tsuneya Ikezu
Journal:  J Neuroimmune Pharmacol       Date:  2008-11-26       Impact factor: 4.147

8.  YY1 and FoxD3 regulate antiretroviral zinc finger protein OTK18 promoter activation induced by HIV-1 infection.

Authors:  James L Buescher; Lindsey B Martinez; Shinji Sato; Satoshi Okuyama; Tsuneya Ikezu
Journal:  J Neuroimmune Pharmacol       Date:  2008-11-25       Impact factor: 4.147

9.  OTK18 levels in plasma and cerebrospinal fluid correlate with viral load and CD8 T-cells in normal and AIDS patients.

Authors:  James L Buescher; Fenghai Duan; Junfeng Sun; Richard W Price; Tsuneya Ikezu
Journal:  J Neuroimmune Pharmacol       Date:  2008-09-05       Impact factor: 4.147

10.  Characterization of gene expression regulated by human OTK18 using Drosophila melanogaster as a model system for innate immunity.

Authors:  Cole R Spresser; Sarah E Marshall; Kimberly A Carlson
Journal:  J Genet       Date:  2008-08       Impact factor: 1.166

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.